Back to User profile » Professor Manfredi Rizzo
Papers published by Professor Manfredi Rizzo:
rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
Naja K, Elashi AA, Hedaya L, Anwardeen NR, Al-Shafai M, Rizzo M, Elrayess MA
Therapeutics and Clinical Risk Management 2026, 22:578286
Published Date: 28 April 2026
Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut Microbiota
Rabbani SA, El-Tanani M, Janić M, Janež A, Tanani YE, Hajeer E, Matalka MI, Rizzo M, Kumar R
Therapeutics and Clinical Risk Management 2025, 21:1701-1733
Published Date: 13 December 2025
Therapeutic Advances in Obesity: How Real-World Evidence Impacts Affordability Beyond Standard of Care
Patoulias D, Koufakis T, Ruža I, El-Tanani M, Rizzo M
Pragmatic and Observational Research 2024, 15:139-149
Published Date: 6 August 2024
Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview
Telci Caklili O, Cesur M, Mikhailidis DP, Rizzo M
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1767-1774
Published Date: 14 June 2023
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction
Rizvi AA, Rizzo M
Diabetes, Metabolic Syndrome and Obesity 2022, 15:1023-1030
Published Date: 5 April 2022